Polysubstituted benzene, preparation method thereof, and method of using the same

US11376228B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11376228-B2
Application numberUS-202016986303-A
CountryUS
Kind codeB2
Filing dateAug 6, 2020
Priority dateFeb 12, 2018
Publication dateJul 5, 2022
Grant dateJul 5, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A polysubstituted benzene compound, preparation method thereof, and method of using the same. The compound has a formula I or I′, where X represents carbon, sulfur, or oxygen; R1 represents a C1-16 alkyl, C2-16 alkenyl, or C2-10 alkynyl; R2 represents hydrogen, halogen, C1-16 alkyl, C2-16 alkenyl, or C2-10 alkynyl; or an aryl group or a substituted aryl group by 1-5 groups selected from halogen, C1-26 alkyl, C1-3 halogenated alkyl, O—C1-3 alkyl, hydroxyl, amino, nitro, cyano group, aldehyde group and ester group; or a heteroaryl group or a substituted heteroaryl group by 1-5 groups selected from halogen, C1-26 alkyl, C1-3 halogenated alkyl, O—C1-3 alkyl, hydroxyl, amino, nitro, cyano group, aldehyde group and ester group; the heteroaryl group is a 3-10-membered heteroaryl group including N, S, O, or a combination thereof.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound, having a formula I or I′: wherein: X represents carbon, sulfur, or oxygen; R 1 represents a C 1-16 alkyl, C 2-16 alkenyl, or C 2-10 alkynyl; R 2 represents hydrogen, halogen, C 1-16 alkyl, C 2-16 alkenyl, or C 2-10 alkynyl; or an aryl group or a substituted aryl group by 1-5 groups selected from halogen, C 1-26 alkyl, C 1-3 halogenated alkyl, O—C 1-3 alkyl, hydroxyl, amino, nitro, cyano group, aldehyde group and ester group; or a heteroaryl group or a substituted heteroaryl group by 1-5 groups selected from halogen, C 1-26 alkyl, C 1-3 halogenated alkyl, O—C 1-3 alkyl, hydroxyl, amino, nitro, cyano group, aldehyde group and ester group; the heteroaryl group is a 3-10-membered heteroaryl group comprising N, S, O, or a combination thereof; R 3 represents C 1-6 aldehyde group, C 2-6 acyl group, —COOH, hydroxyl-substituted C 1-6 alkyl, —CH 2 O—C 1-6 alkyl or —CO 2 —C 1-6 alkyl; R 4 and R 7 , at each occurrence, represent hydrogen, a C 1-20 alkyl, C 2-36 alkenyl, or C 2-10 alkynyl; or an aryl group or a substituted aryl group by 1-5 groups selected from halogen, C 1-3 halogenated alkyl, O—C 1-3 alkyl, C 1-25 alkyl, hydroxyl, amino, nitro, cyano group, aldehyde group and ester group; R 5 and R 6 , at each occurrence, represent hydrogen, C 1-6 alkyl or C 1-6 silicon; wherein the dotted line in formula I optionally comprises a carbon chain connecting R 4 to X; and wherein the dotted line in formula I′ optionally comprises a carbon chain connecting R 4 to X. 2. The compound of claim 1 , wherein: X represents carbon, sulfur, or oxygen; R 1 represents a C 1-4 alkyl, C 2-4 alkenyl, or C 3-7 alkynyl; R 2 represents hydrogen, halogen, C 1-4 alkyl, C 2-4 alkenyl, or C 3-7 alkynyl; or an aryl group or a substituted aryl group by 1-5 groups selected from halogen, C 1-26 alkyl, C 1-3 halogenated alkyl, O—C 1-3 alkyl, hydroxyl, amino, nitro, cyano group, aldehyde group and ester group; or a heteroaryl group or a substituted heteroaryl group by 1-5 groups selected from halogen, C 1-6 alkyl, C 1-3 halogenated alkyl, O—C 1-3 alkyl, hydroxyl, amino, nitro, cyano group, aldehyde group and ester group; R 3 represents C 1-6 aldehyde group, C 2-6 acyl group, —COOH, hydroxyl-substituted C 1-4 alkyl, —CH 2 O—C 1-4 alkyl or —CO 2 —C 1-6 alkyl; R 4 and R 7 , at each occurrence, represent hydrogen, C 1-20 alkyl, C 2-36 alkenyl, or C 2-10 alkynyl; or an aryl group or a substituted aryl group by 1-5 groups selected from halogen, C 1-3 halogenated alkyl, O—C 1-3 alkyl, C 1-25 alkyl, hydroxyl, amino, nitro, cyano group, aldehyde group and ester group; and R 5 and R 6 , at each occurrence, represent hydrogen or C 1-4 alkyl. 3. The compound of claim 1 , wherein: X represents carbon, sulfur, or oxygen; R 1 represents a C 1-3 alkyl, allyl, or C 3-4 alkynyl; R 2 represents hydrogen, halogen, C 1-4 alkyl, allyl, or C 3-7 alkynyl; or an aryl group or a substituted aryl group by 1-5 groups selected from halogen, methyl, methoxyl, C 2-26 alkyl, hydroxyl, nitro, cyano group, aldehyde group and ester group; or a heteroaryl group or a substituted heteroaryl group by 1-5 groups selected from halogen, C 1-6 alkyl, C 1-3 halogenated alkyl, O—C 1-3 alkyl, hydroxyl, nitro, cyano group, aldehyde group and ester group; the heteroaryl group is a 5-6-membered heteroaryl group comprising N, S, O, or a combination thereof; R 3 represents C 1-3 aldehyde group, C 2-4 acyl group, —COOH, hydroxyl-substituted C 1-4 alkyl, —CH 2 O—C 1-4 alkyl or —CO 2 —C 1-4 alkyl; R 4 and R 7 , at each occurrence, represent hydrogen, a C 1-17 alkyl, C 2-36 alkenyl, or C 2-10 alkynyl; or an aryl group or a substituted aryl group by 1-5 groups selected from halogen, methoxyl, C 1-25 alkyl, hydroxyl, nitro, cyano group, aldehyde group and ester group; and R 5 and R 6 , at each occurrence, represent hydrogen or methyl. 4. The compound of claim 1 , wherein: X represents carbon, sulfur, or oxygen; R 1 represents a C 1-3 alkyl, allyl, or C 3-4 alkynyl; R 2 represents hydrogen, halogen, C 1-4 alkyl, allyl, or C 3-7 alkynyl; or an aryl group or a substituted aryl group by 1-5 groups selected from halogen, methyl, methoxyl, C 2-26 alkyl, hydroxyl, nitro, cyano group, aldehyde group and ester group; R 3 represents C 1-3 aldehyde group, acetyl group, —COOH, hydroxyl-substituted C 1-4 alkyl, —CH 2 O—C 1-4 alkyl or —CO 2 —C 1-4 alkyl; R 4 and R 7 , at each occurrence, represent hydrogen, C 1-17 alkyl, C 2-36 alkenyl, or C 2-10 alkynyl; or an aryl group or a substituted aryl group by 1-5 groups selected from halogen, methoxyl, C 1-25 alkyl, hydroxyl, nitro, cyano group, aldehyde group and ester group; and R 5 and R 6 , at each occurrence, represent hydrogen or methyl. 5. The compound of claim 1 , wherein X represents carbon, sulfur, or oxygen; R 1 represents a C 1-3 alkyl, allyl, or C 3-4 alkynyl; R 2 represents hydrogen, halogen, C 1-4 alkyl, allyl, or C 3-7 alkynyl; or an aryl group or a substituted aryl group by 1-5 groups selected from halogen, methyl, methoxyl, C 2-26 alkyl, hydroxyl, nitro, cyano group, aldehyde group and ester group; or a heteroaryl group or a substituted heteroaryl group by 1-5 groups selected from halogen, C 1-6 alkyl, C 1-3 halogenated alkyl, O—C 1-3 alkyl, hydroxyl, nitro, cyano group, aldehyde group and ester group; the heteroaryl group is a 5-6-membered heteroaryl group comprising N, S, O, or a combination thereof; R 3 represents formyl, acetyl, —COOH, hydroxyl-substituted C 1-2 alkyl, —CH 2 O—C 1-2 alkyl or —CO 2 —C 1-4 alkyl; R 4 and R 7 , at each occurrence, represent hydrogen, C 1-17 alkyl, C 2-36 alkenyl, or C 2-10 alkynyl; or an aryl group or a substituted aryl group by 1-5 groups selected from halogen, methoxyl, C 1-25 alkyl, hydroxyl, nitro, cyano group, aldehyde group and an ester group; and R 5 and R 6 , at each occurrence, represent hydrogen or methyl. 6. The compound of claim 1 , wherein the compound has one of the following formulas: 7. A pharmaceutical composition, comprising the compound of claim 1 and a pharmaceutically acceptable excipient.

Assignees

Inventors

Classifications

  • A61K31/09Primary

    having two or more such linkages · CPC title

  • C07D309/26Primary

    Carboxaldehyde radicals · CPC title

  • Singly bound oxygen atoms · CPC title

  • Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom · CPC title

  • in six-membered rings · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11376228B2 cover?
A polysubstituted benzene compound, preparation method thereof, and method of using the same. The compound has a formula I or I′, where X represents carbon, sulfur, or oxygen; R1 represents a C1-16 alkyl, C2-16 alkenyl, or C2-10 alkynyl; R2 represents hydrogen, halogen, C1-16 alkyl, C2-16 alkenyl, or C2-10 alkynyl; or an aryl group or a substituted aryl group by 1-5 groups selected from halogen…
Who is the assignee on this patent?
Genifarm Laboratories Inc, Univ South China Tech
What technology area does this patent fall under?
Primary CPC classification A61K31/09. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).